Home
 
Home
Stock Research
Fund Research
Markets
Forex
Options
Retirement
Real Estate
News
Commentary
University
Featured Content
Free Newsletters
Financial Glossary
Business Glossary
The market in:
: :
GSK Overview
GSK Charts
GSK News
GSK Profile
GSK Analysis
GSK Offers

InvestorGuide Stock Analysis

GlaxoSmithKline Ends One Partnership, but Starts Another
Excerpt from the InvestorGuide.com Stock of the Day on 6/15/2009

Over the years, pharmaceutical company GlaxoSmithKline has engaged in partnerships with many other companies, working together to develop a number of different pharmaceutical products. Some have failed, while others have succeeded, which is a common result in the medical field where it takes a lot of experimentation and evaluation to judge the performance of any new drug. GlaxoSmithKline's announcements this morning were symbolic and indicative of the ups and downs that they themselves, as well as many other companies, have gone through throughout the years.

One of Glaxo's announcements was the proclamation of a new partnership with Dr. Reddy's Laboratories Ltd. (RDY: Charts, News, Offers). Dr. Reddy's is a pharmaceutical company based on India, and the two companies have decided to work together to develop and market new and existing products in some areas where the companies are not currently focused. These products will be developed by Dr. Reddy's, and probably co-marketed by both companies, and the new partnership will be targeting these products in Africa, the Middle East, Asia Pacific and Latin America. Full details of the deal have not yet been released, but the deal will allow both companies to expand their reach, and take advantage of each other's strengths. More >

Subscribe to the Stock of the Day!
 

Add to tracker
What is Morningstar's rating for GlaxoSmithKline PLC?

InvestorGuide Stock of the Day RSS feed

RSS

Trading Offers

•
Buy GlaxoSmithKline PLC for just $4

Special Offers

•
Learn to spot opportunities in any market with a Risk-Free* 30-day trial from Investools.

Morningstar Analysis for GlaxoSmithKline PLC

GlaxoSmithKline PLC (GSK) Upgrades

Date
Analyst
Old Rating
New Rating
10/16/2008
Merrill Lynch
Underperform
Neutral
02/11/2008
UBS
Neutral
Buy
02/09/2007
Bear Stearns
Peer Perform
Underperform
11/03/2005
Bear Stearns
Peer Perform
N/A
08/18/2005
JP Morgan
Neutral
N/A

GlaxoSmithKline PLC (GSK) Downgrades

Date
Analyst
Old Rating
New Rating
10/23/2009
Jefferies & Co
Buy
Hold
11/14/2008
UBS
Buy
Neutral
09/08/2008
Goldman Sachs
Neutral
Sell
05/27/2008
Morgan Stanley
Equalweight
Underweight
07/25/2007
Bear Stearns
Peer Perform
Underperform
03/22/2007
J.P. Morgan
Underweight
Neutral

GlaxoSmithKline PLC (GSK) New Coverage

Date
Analyst
Rating
03/17/2009
Credit Suisse
Outperform
01/26/2009
Jefferies & Co
Buy
Buy GlaxoSmithKline PLC for just $4

Special Offers

Buy GlaxoSmithKline PLC for just $4
www.sharebuilder.com
What is Morningstar's rating for GlaxoSmithKline PLC?
www.morningstar.com

Learn to spot opportunities in any market with a Risk-Free* 30-day trial from Investools.
www.investools.com
Trade Forex with FXSolutions. Sign up for FREE $10,000 Practice Account.
www.fxsolutions.com
Download a free Options Fundamentals Podcast, from The Options Industry Council.
OptionsEducation.org

GSK Links

Guru Analysis:
MSN Money | Morningstar | Stock Consultant

Analyst Opinions:
Reuters | SmartMoney | MarketWatch | Nasdaq | BarChart | Schaeffers | CNN Money | TheStreet

Blogs:
SocialPicks | Topix.net | SeekingAlpha | Technorati | Ask.com

Message Boards:
ClearStation | RagingBull | Yahoo | Investopedia | FreeRealTime | StockHouse Trading Offers:
Buy GSK for just $4

Competitor Analysis

GlaxoSmithKline PLC
Merck & Company
Astrazeneca PLC
Shire
Get Analysis For: